-

1st Detect Lands First Purchase Order for Checkpoint Security

AUSTIN, Texas--(BUSINESS WIRE)--Astrotech Corporation (NASDAQ: ASTC) announced today that its 1st Detect subsidiary has secured an important landmark purchase order for its TRACER 1000™, representing the first units to be deployed at an airport security checkpoint. Including prior sales to worldwide cargo facilities, the TRACER 1000 explosives trace detector (ETD) will now be operating in fifteen locations in ten countries throughout Europe and Asia.

The Astrotech Mass Spectrometer Technology™ (AMS Technology) drives the breakthrough TRACER 1000, the first certified ETD to employ mass spectrometry. Long recognized as the gold standard in chemical detection, mass spectrometry has historically been too costly, bulky, and cumbersome to be used outside of the laboratory. Unlike other technologies, the AMS Technology works under ultra-high vacuum, which eliminates competing molecules that can impair the accuracy and quality of an analysis. The TRACER 1000 is inexpensive, small, and easy to use, with high resolution and near-zero false alarms. Due to its high sensitivity and rugged design, the TRACER 1000 is the only mass spectrometry-based ETD to have received European Civil Aviation Conference (ECAC) certification for both checkpoint and cargo security.

“As air travel spending begins to return to normal following the slowdown caused by the COVID-19 pandemic, we are seeing renewed interest in checkpoint use for the TRACER 1000 ETD,” said Thomas B. Pickens, Chairman and Chief Executive Officer of 1st Detect. “We are excited that airport operators are beginning to understand that mass spectrometry is a superior technology for the detection of explosives, providing benefits to both airports and travelers. Based on our near-zero false alarms, we believe that operating costs will be considerably lower and passenger throughput will be much faster when compared to competing screening devices. This could lead to more consumer spending in airports as passengers avoid unnecessary delays at the screening checkpoint,” concluded Pickens.

About Astrotech Corporation
Astrotech (NASDAQ: ASTC) is a mass spectrometry company that launches, manages, and commercializes scalable companies based on its innovative core technology. 1st Detect is a manufacturer of explosives and narcotics trace detectors developed for use at airports, cargo and other secured facilities, and borders worldwide. Astrotech is headquartered in Austin, Texas. For information, please visit www.astrotechcorp.com.

This press release contains forward-looking statements that are made pursuant to the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements are subject to risks, trends, and uncertainties that could cause actual results to be materially different from the forward-looking statement. These factors include, but are not limited to, whether we can successfully develop our proprietary technologies and whether the market will accept our products and services, as well as other risk factors and business considerations described in the Company’s Securities and Exchange Commission filings including the annual report on Form 10-K. Any forward-looking statements in this document should be evaluated in light of these important risk factors. The Company assumes no obligation to update these forward-looking statements.

Contacts

Eric Stober
Chief Financial Officer
Astrotech Corporation
(512) 485-9530

Astrotech Corporation

NASDAQ:ASTC

Release Versions

Contacts

Eric Stober
Chief Financial Officer
Astrotech Corporation
(512) 485-9530

More News From Astrotech Corporation

Astrotech Announces Date for Fiscal Year 2022 Annual Meeting and Deadlines for Stockholder Proposals

AUSTIN, Texas--(BUSINESS WIRE)--Astrotech Corporation (Nasdaq: ASTC) (the “Company”) announced its plans to hold its fiscal year 2022 annual meeting of stockholders (the “2022 Annual Meeting”) on Tuesday, November 15, 2022. The 2022 Annual Meeting will be held at 9:00 a.m. Central Time. Current plans are for the meeting to be in person in Austin, Texas at the Company’s main office. The Company anticipates sending proxy materials for the annual meeting to stockholders in September 2022. Astrotec...

Astrotech Appoints Jim Becker to Board of Directors

AUSTIN, Texas--(BUSINESS WIRE)--Astrotech Corporation announces that it has appointed Jim Becker to its Board of Directors....

Astrotech Subsidiary and Cleveland Clinic Expand Breath Analysis Study to Detect Multiple Diseases

AUSTIN, Texas--(BUSINESS WIRE)--Astrotech Corporation announces it has amended its Joint Development and Option Agreement with Cleveland Clinic to include additional areas of focus....
Back to Newsroom